Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Position Increased by Yousif Capital Management LLC

Yousif Capital Management LLC raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 5.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 215,156 shares of the pharmacy operator’s stock after purchasing an additional 11,133 shares during the quarter. Yousif Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $2,403,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Walgreens Boots Alliance by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock worth $805,506,000 after buying an additional 2,279,495 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Walgreens Boots Alliance by 8.8% during the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator’s stock worth $303,902,000 after acquiring an additional 2,631,332 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Walgreens Boots Alliance by 5.2% during the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator’s stock valued at $194,082,000 after acquiring an additional 1,020,587 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after acquiring an additional 2,185,950 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in Walgreens Boots Alliance by 18.8% in the 4th quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator’s stock worth $83,007,000 after purchasing an additional 1,407,973 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $11.39 on Friday. The firm’s 50-day moving average is $11.09 and its 200-day moving average is $10.68. The company has a market cap of $9.86 billion, a price-to-earnings ratio of -1.11, a PEG ratio of 1.31 and a beta of 0.78. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $16.25.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. During the same period in the previous year, the company posted $1.20 earnings per share. The company’s quarterly revenue was up 4.1% compared to the same quarter last year. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on WBA shares. Wall Street Zen initiated coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They set a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and lowered their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $10.59.

Get Our Latest Report on WBA

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Chairman Stefano Pessina purchased 832,258 shares of the business’s stock in a transaction on Sunday, April 27th. The stock was purchased at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the purchase, the chairman now directly owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 17.50% of the company’s stock.

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.